tailieunhanh - MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer

Primary systemic treatment for ovarian cancer is surgery, followed by platinum based chemotherapy. Platinum resistant cancers progress/recur in approximately 25% of cases within six months. We aimed to identify clinically useful biomarkers of platinum resistance. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN